Effect of Famotidine on Covid-19: Killing Virus or Opposing Ards? Publisher



Hosseini MS¹ ; Davoudimonfared E¹ ; Najmeddin F¹ ; Mojtahedzadeh M¹ Show Affiliations
Source: Pulmonary Therapy Published:2023

Abstract

Since the first detection of SARS-CoV-2 in China, COVID-19 (Corona Virus Disease 2019) has taken the lives of more than six million people. Although some antivirals seem proper for treatment, the investigation of finding the best therapeutic approach for COVID-19 is still continuing. Some observational research showed that famotidine has promising effects in addition to its acid-suppressing characteristics in the treatment of COVID-19. The definite viricidal effect of famotidine is not established. Opposing acute respiratory distress syndrome (ARDS) can be proposed as a probable mechanism for the action of famotidine, due to its inhibitory effect on histamine release, inhibition of transmembrane protease serine S (TMPRSS) and stabilizing glycocalyx. These hypotheses should be under investigation in the future. © 2023, The Author(s).